Travere Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:TVTX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 607.44 M776.63 M672.59 M788.91 M594.13 M605.19 M 총 부채 396.23 M474.52 M629.73 M588.1 M535.05 M490.36 M 자본금 총액 211.21 M302.11 M42.85 M200.81 M59.08 M114.83 M 총 부채 및 주주자본 607.44 M776.63 M672.59 M788.91 M594.13 M605.19 M 총부채 215.34 M226.58 M375.55 M377.26 M378.99 M311.72 M 순부채 -141.23 M-201.36 M28.33 M70.45 M320.45 M73.31 M

뉴스

Redwire Stock, Comfort Systems, 15 Others Join IBD Watchlists

Dow Jones Leader Amazon, AI Stock Quanta, Monster Beverage In Or Near Buy Zones

AstraZeneca Stock: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins (NYSE:AZN)

Computer Giant Dell Leads 10 Newcomers To Big Cap 20, Other Best Stock Lists

Travere, IBD Stock Of The Day, Is On Path To $3 Billion And In A Buy Zone

Travere Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-05-07

Nvidia, Amazon, SiTime Among New Names On IBD 50, Stock Spotlight And More

Travere Therapeutics Analysts Increase Their Forecasts Following Q1 Earnings - Travere Therapeutics (NASD

Travere Therapeutics, Inc. (TVTX) Q1 2026 Earnings Call Transcript

Compared to Estimates, Travere (TVTX) Q1 Earnings: A Look at Key Metrics

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone